CME 2026 ASLMS 45th Annual Conference Recordings - Beyond Human Insight: AI in the Age of Aesthetic Innovation
The course was recorded on May 9, 2026, at the ASLMS Annual Conference.
Course Description:
Artificial intelligence is rapidly reshaping aesthetic medicine from imaging and diagnosis to treatment planning, workflow efficiency, and safety monitoring. This session demystifies practical AI for lasers, energy-based devices, injectables, and body contouring. Faculty will translate core concepts into everyday clinical use. We will review evidence, real-world cases, and regulatory considerations.
COURSE DIRECTORS: Lilit Garibyan, MD, PhD; Zakia Rahman, MD
FACULTY PANELISTS: Kerrie Jiang, MSN, NP; Arlene Ruiz de Luzuriaga, MPH, MBA, MD – Dermatologist, University of Chicago, Dept. of Medicine, Section of Dermatology; Diala Haykal, MD – Laser Aesthetic Medical Center; Shlomit Halachmi, MD, PhD – Founder and CEO, Building 66
LEARNING OBJECTIVES:
At the end of the activity, learners should be able to:
- Evaluate an AI tool using clinically relevant performance metrics
- Discuss AI uses with lasers/EBDs/injectables
TARGET AUDIENCE:
This activity is intended for an audience of physicians and other healthcare professionals interested in the use of lasers, light, energy-based devices, and related technologies across various specialties.
PRESENTATIONS:
How Industry R&D Can Leverage AI | Kerrie Jiang, MSN, NP
Ethical Consideration in the Use of AI | Arlene Ruiz de Luzuriaga, MPH, MBA, MD – Dermatologist, University of Chicago, Dept. of Medicine, Section of Dermatology
AI In Energy Based Devices | Diala Haykal, MD – Laser Aesthetic Medical Center
Behind the Paradigm for AI in Assessing Skin Lesions | Shlomit Halachmi, MD, PhD – Founder and CEO, Building 66
BACKGROUND REQUIREMENTS:
Participants with a basic understanding of skin biology and physics will derive maximal benefit from the presentations, however, all meeting attendees are welcome to attend and contribute.
DISCLOSURES:
The American Society for Laser Medicine and Surgery (ASLMS) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by ASLMS are required to disclose all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are identified as relevant and mitigated by ASLMS in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by ASLMS to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by ASLMS.
All planners and faculty for this educational activity, except for those listed below, have no financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
- Lilit Garibyan, MD, PhD discloses the following financial relationships Annecy Bio: Biomedical Start-up Owner/Employee (that has begun the regulatory process), Owner/Co-Owner Founder/Co-Founder; Brixton Bio: Biomedical Start-up Owner/Employee (that has begun the regulatory process), Consulting Fees (e.g., advisory boards), Owner/Co-Owner Founder/Co-Founder; Clarity Cosmetics: Investor, Stock Shareholder (Individual stocks; diversified mutual funds do not need to be disclosed); EyeCool: Biomedical Start-up Owner/Employee (that has begun the regulatory process), Owner/Co-Owner Founder/Co-Founder; Face of Angel: Founder - non-profit, Owner/Co-Owner Founder/Co-Founder; Magic Wand Initiative: co-founder - educational program, Owner/Co-Owner Founder/Co-Founder; Mass General Hospital: Assigned to Mass General Hospital who receives royalties and IP right from my inventions, Employee, Royalty/Patent Beneficiary; Massachusetts General Hospital; Massachusetts Dermatology Associates: Employee (Ongoing); MVS: Owner/Co-Owner Founder/Co-Founder; NIH: Contracted Research (Principal Investigators must provide information, even if received by the institution); Sinclair Aesthetic: Honoraria
- Zakia Rahman, MD discloses the following financial relationships: AbbVie, Allergan: Consulting Fees (e.g., advisory boards), Speakers' Bureau; Estée Lauder: Consulting
- Kerrie Jiang, MSN, NP discloses the following financial relationships: AGNES Medical: Consultant; Akeyna: Consultant; Cytrellis Biosystems, inc: Consulting Fees (e.g., advisory boards); Merz Aesthetics: Former Employee; SnigTag/BioDesign Stanford: Consultant
ASLMS staff planners and reviewers have no relevant financial relationships to disclose.
ACCME Accreditation Statement:
The American Society for Laser Medicine and Surgery, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement:
The American Society for Laser Medicine and Surgery, Inc. designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credits:
This enduring material is eligible for 1.6 CE credits if you are a Registered Nurse. These credits are provided with co-sponsorship with the Laser Training Institute division of Professional Medical Education Association.
Instructions for Learners to Receive Credit:
To receive a Certificate of Credit or a Certificate of Participation for the On-Demand (2026) course, registered attendees must submit a completed electronic CME/CE evaluation by the course expiration date (11/30/26).
This course should take approximately 1.5 hours to complete.
REFUND/CANCELLATION POLICY:
For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283.
- Refund requests will only be considered if made within 14 days of purchase.
- Refunds will only be considered if you have not yet started the course (no content viewed).
- Refunds are not available for missed live activities.
- Contact information@aslms.org to request a refund.
CONTACT INFORMATION:
For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283.
DISCLAIMER:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
DISCLOSURE OF OFF-LABEL USE:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The American Society for Laser Medicine & Surgery does not recommend the use of any agent outside of the labeled indications.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
Lilit Garibyan, MD, PhD (Moderator)
1. Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 2. Department of Dermatology, Harvard Medical School, Boston, MA
Dr. Lilit Garibyan is a board-certified, practicing dermatologist and Associate Professor of dermatology at Harvard Medical School and Physician-Scientist at Wellman Center for Photomedicine at Massachusetts General Hospital. She has expertise in cutting edge translational research in areas of device development, dermatology, cutaneous neurobiology, adipose tissue, and immunology. She has spent 20+ years at Harvard Medical School, where she has taught and trained students, residents and fellows in dermatology, laser and energy-based devices, and in problem-based innovation. Her research focuses on innovative biomedical translational discoveries aimed at identifying unmet medical needs and working with multidisciplinary teams to develop novel treatments for those needs. Dr. Garibyan is an inventor on >16 pending and granted patents, has published over 60 original, peer-reviewed publications and has obtained over $5.3 million grant funding from Department of Defense and NIH for her innovative research. She is the inventor of a platform cooling technology with various therapeutic applications that has led to three venture-backed, start-up companies. She is the scientific co-founder of two of those companies.
Dr. Garibyan is the co-founder and the Director of the “Magic Wand Initiative” and the “Virtual Magic Wand” programs, which teach the process of innovation to clinicians. These internationally-recognized programs empower, engage, and teach healthcare professionals on how to identify unmet needs and collaborate to identify and implement solutions to problems. Dr Garibyan has given many national and international lectures on the topic of engaging clinicians in problem-based innovation. She had directed sessions and led workshops in national and international meetings designed to engage healthcare workers in innovation.
Dr. Garibyan received her B.S. summa cum laude from University of California Los Angeles, her M.D. from Harvard Medical School, and her Ph.D. from Harvard University in Experimental Pathology/Immunology.
Zakia Rahman, MD (Moderator)
Kerrie Jiang, MSN, NP
Kerrie Jiang, RN, MSN
Kerrie Jiang is a product development specialist with over two decades of experience leading the development and commercialization of cutting-edge medical aesthetic devices. She has successfully lauched more than 20 products to global markets, including EU, China, Korea and Japan. She takes pride in working with multiple first-in-class technologies from novel concept to global commercial success, covering energy sources from the first non-ablative and ablative fractional lasers, radiofrequency, cryolipolysis, electromagnetic stimulation, to high-intensity focused ultrasound. Additionally, her career spans leadership roles at industry giants such as Allergan and Merz, where she led multi-functional teams across engineering, clinical affairs, regulatory strategy and medical affairs. From start-ups to multi-national corporations, she is keenly aware of the various organizational strengths that can accelerate product development.
Currently, Kerrie partners with early-stage startups to build products that are clinically meaningful, commercially viable, and regulatory-ready from day one. She specializes in aligning product development with market needs, accelerating clinical validation, and crafting regulatory strategies that enable speed-to-market in highly regulated environments. Her passion lies in solving real life challenges through innovative, evidence-backed technologies that empower both practitioners and patients.
Arlene Ruiz de Luzuriaga, MPH, MBA, MD
Dermatologist
University of Chicago, Dept. of Medicine, Section of Dermatology
Arlene Ruiz de Luzuriaga is an Associate Professor of Medicine in the Section of Dermatology, Co-director of the Pigmented Lesion Clinic, and Vice-Chief for Dermatopathology Operations at the University of Chicago. Her clinical focus is on total body photography, dermoscopy, skin cancer surveillance, and melanoma prevention and early detection. She is interested in use of technology for the improvement of patient care, diagnosis and treatment algorithms, quality improvement, and medical education.
Through her role as the Director of Innovation and Digital Technology for the Bucksbaum-Siegler Institute for Clinical Excellence at the University of Chicago, she seeks to support initiatives and research that examine how the patient-doctor relationship is affected by the implementation of digital health technology and artificial intelligence, and how this can serve to guide the development and incorporation of such innovations in healthcare.
Diala Haykal, MD
Dr
Centre Laser Palaiseau
Dr Diala Haykal is a Cosmetic and Laser Doctor, running her own specialized clinic and training center, Centre Médical Laser Esthétique Palaiseau, in France, offering patients a wide range of modern cosmetic treatments. She holds a diploma in Aesthetic Medicine and Lasers from Paris V Descartes University. Additionally, she holds an American Board diploma in Aesthetic Medicine from the American Academy of Aesthetic Medicine, where she is also a trainer and expert in the American Academy of Continuous Education. She has also completed Leadership in HealthCare programs at HEC Business School, as well as at Harvard University and Cambridge Judge Business School. Furthermore, she has pursued studies in Artificial Intelligence in HealthCare at both Harvard University and MIT Sloan Management School.
In addition to her academic achievements, Dr. Haykal serves as a tutor and supervisor at Paris-Sorbonne University. Alongside her numerous achievements, she has made significant contributions through her international publications in cosmetic dermatology and lasers. She is also a reviewer for esteemed journals in her domain and serves as an editor for several scientific journals. Her expertise extends beyond academia as she acts as an international speaker and KOL for various industries. Dr. Haykal is an esteemed member of the American Board of Aesthetic Medicine and actively participates in professional societies such as the French Society of Lasers in Dermatology, the European Society for Lasers and Energy-Based Devices, and the French Society of Cosmetic Medicine. She is also a member of the European AI Alliance, showcasing her involvement in the field of artificial intelligence within the healthcare domain.
Shlomit Halachmi, MD, PhD
Dr. Shlomit Halachmi studied chemical engineering and biology at MIT, after which she studied medicine and molecular biology at Harvard Medical School, and completed her dermatology training at the combined Boston University/Tufts University residency program. In addition to her clinical dermatology experience, which focuses on lasers and other energy-based devices, she has worked in senior positions in drug and medical device development as well as at the FDA.
Key:
Complete
Next
Failed
Available
Locked